Tectonic Therapeutic Overview

  • Founded
  • 2019

  • Status
  • Private

  • Employees
  • 34

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $80.1M

  • Investors
  • 5

Tectonic Therapeutic General Information


Operator of a clinical biotechnology company intended to develop novel GPCR-targeted therapies. The company specializes in the research and development of therapeutics that address clinical challenges relevant to a broad range of patients suffering from cardiovascular diseases, dysregulated inflammation and other conditions, enabling the healthcare industry to improve medical procedures in an efficient manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 490 Arsenal Way
  • Suite 210
  • Watertown, MA 02472
  • United States

Tectonic Therapeutic Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tectonic Therapeutic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 15-Apr-2021 $80.1M 000.00 Completed Pre-Clinical Trials
1. Grant 21-May-2020 0000 Completed Startup
To view Tectonic Therapeutic’s complete valuation and funding history, request access »

Tectonic Therapeutic Executive Team (8)

Name Title Board Seat Contact Info
Anthony Muslin Chief Development Officer
Peter McNamara Ph.D Chief Scientific Officer
Marc Schwabish Ph.D Chief Business Officer & Senior Vice President, Business Development
Andrew Kruse Ph.D Co-Founder, Advisor & Board Member
Marcella Ruddy MD Chief Medical Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Tectonic Therapeutic Board Members (6)

Name Representing Role Since
Andrew Kruse Ph.D Tectonic Therapeutic Co-Founder, Advisor & Board Member 000 0000
Christian Cortis Ph.D Self Chief Operating Officer & Board Member 000 0000
Praveen Tipirneni MD Self Board Member 000 0000
Stefan Vitorovic Self Board Member 000 0000
Terrance McGuire Polaris Partners Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »

Tectonic Therapeutic Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tectonic Therapeutic Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EcoR1 Capital Hedge Fund Minority 000 0000 000000 0
Institute for Protein Innovation Corporation Minority 000 0000 000000 0
Polaris Partners Venture Capital Minority 000 0000 000000 0
Vida Ventures (Boston) Venture Capital Minority 000 0000 000000 0
Harvard President's Challenge University 000 0000 000000 0
To view Tectonic Therapeutic’s complete investors history, request access »